Øystein Rekdal

Chief Executive Officer at LYTIX BIOPHARMA

Net worth: 70 776 $ as of 29/04/2024

Health Technology

Consumer Services

Øystein Rekdal active positions

Companies	Position	Start	End
LYTIX BIOPHARMA	Chief Executive Officer	10/09/2019	-
	Founder	31/12/2002	-
	Director/Board Member	25/04/2010	20/04/2011
	Chief Tech/Sci/R&D Officer	-	10/09/2019
	Corporate Officer/Principal	31/12/2002	-
University of Tromso	Corporate Officer/Principal	-	-

Companies	Position	Start	End
Prophylix AS Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.	Director/Board Member	14/04/2010	-

University of Tromso

Doctorate Degree

International

Norway

Operational

Director/Board Member	2
Corporate Officer/Principal	2
Chief Executive Officer	1

Sectoral

Health Technology	3
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
LYTIX BIOPHARMA	Health Technology

Private companies	1
Prophylix AS Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway.	Health Technology

Private companies

Health Technology